Qingjun Chen, Wenwu Yin, Zhenggang Zhu, Chuanlin Wang. The Clinical Advantages of Anti-Rabies Monoclonal Antibodies in Post-Exposure Prophylaxis — Worldwide, 2016–2025J. China CDC Weekly, 2025, 7(39): 1258-1262. DOI: 10.46234/ccdcw2025.212
|
Citation:
|
Qingjun Chen, Wenwu Yin, Zhenggang Zhu, Chuanlin Wang. The Clinical Advantages of Anti-Rabies Monoclonal Antibodies in Post-Exposure Prophylaxis — Worldwide, 2016–2025J. China CDC Weekly, 2025, 7(39): 1258-1262. DOI: 10.46234/ccdcw2025.212
|
Qingjun Chen, Wenwu Yin, Zhenggang Zhu, Chuanlin Wang. The Clinical Advantages of Anti-Rabies Monoclonal Antibodies in Post-Exposure Prophylaxis — Worldwide, 2016–2025J. China CDC Weekly, 2025, 7(39): 1258-1262. DOI: 10.46234/ccdcw2025.212
|
Citation:
|
Qingjun Chen, Wenwu Yin, Zhenggang Zhu, Chuanlin Wang. The Clinical Advantages of Anti-Rabies Monoclonal Antibodies in Post-Exposure Prophylaxis — Worldwide, 2016–2025J. China CDC Weekly, 2025, 7(39): 1258-1262. DOI: 10.46234/ccdcw2025.212
|